StockVS

NYSE · Asset Management · USD

The Gabelli Healthcare & Wellness Trust (GRX) Stock Analysis

The Gabelli Healthcare & Wellness Trust (GRX) is a Asset Management stock listed on NYSE and quoted in US Dollar.

GRX

$10.03

−$0.06 (−0.59%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare GRX with… →

GRX Key Statistics

As of Sep 4, 2026
Trading
Open
$10.02
Previous Close
$10.09
Day's Range
10.02–10.06
52-Week Range
8.80–10.20
Volume
7.60K
Valuation
P/E Ratio
66.87
EPS (ttm)Profit attributable to each share over the last twelve months.
0.15
Financials (FY)
Revenue (FY)
$2.97M+765.31%
Net Income (FY)
$2.29M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
1-Year Return
+13.79%
Dividend and dates
Dividend
$0.68+6.74%
Ex-Dividend Date
September 16, 2026
Avg Volume
22.99K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

GRX Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+8.06%
2025+7.03%
2024+9.58%
2023−3.32%
2022−19.95%
2021+22.07%
2020+9.83%
2019+31.31%
2018−5.75%
2017+15.03%
2016 (partial year)−13.48%

As of September 4, 2026.

GRX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.97M$2.29M77.3%
2024$342.91K−$285.00K−83.1%
2023$1.24M$422.80K34.1%
2022−$46.71M−$47.44M101.6%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.97M$2.29M77.3%
2024$342.91K−$285.00K−83.1%
2023$1.24M$422.80K34.1%
2022−$46.71M−$47.44M101.6%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

GRX Dividend History

$0.66+10.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.342
2025$0.664+10.0%
2024$0.604+0.0%
2023$0.604+0.0%
YearDividends per sharePaymentsChange
2026 (partial year)$0.342
2025$0.664+10.0%
2024$0.604+0.0%
2023$0.604+0.0%
2022$0.604−37.5%
2021$0.965+65.5%
2020$0.584+3.6%
2019$0.564+7.7%
2018$0.524+0.0%
2017$0.524+100.0%
2016$0.262

Most recent payment: $0.17 per share, ex-dividend June 15, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

GRX Valuation vs Asset Management Median

Median of 561 stocks
MetricGRXAsset Management medianvs median
P/E66.8710.346.5x the median
Profit margin0.00%24.09%24.1 pts below

Medians across 561 Asset Management stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The Gabelli Healthcare & Wellness Trust trades under the ticker GRX. It is classified in the Asset Management industry, within the Financial Services sector.

GRX last closed at $10.03 on September 4, 2026. That is −$0.06 (−0.59%) against the previous close. Over the past 52 weeks the price has ranged from $8.80 to $10.20. The latest close sits 13.98% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $2.97M. Against the prior fiscal year total of $342.91K, that is a change of +765.31%. The same year closed with net income of $2.29M. Profit margin runs at 0%. That is 24.1 percentage points below the Asset Management median of 24.09%. Earnings per share on a trailing basis come to 0.15.

Across the 4 fiscal years on file, revenue moves from −$46.71M in 2022 to $2.97M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 66.87. That is 6.5 times the Asset Management median of 10.34. 561 Asset Management companies report these metrics, and the medians quoted come from that group.

Daily returns over the trailing 10 years annualize to a volatility of 17.43%. The trailing one-year price return is +13.79%. Measured over 10 years, that is +5.15% a year compounded.

Growth & Income

Shareholders receive a dividend, yielding 6.74% on the latest price. That is 1.4 percentage points below the Asset Management median yield of 8.11%. At the indicated rate that is $0.68 a share a year. The ex-dividend date on file is September 16, 2026. Dividends are recorded for 11 calendar years; 2026 shows 2 payments totalling $0.34 a share. The year before, 2025, totalled $0.66 a share.

Across the complete calendar years on file, 2019 returned +31.31% and 2022 returned −19.95%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the price is +8.06% year to date.

Peer Comparison

The Gabelli Healthcare & Wellness Trust (GRX) operates in the Asset Management industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
The Gabelli Healthcare & Wellness Trust GRX 66.9
BlackRock, Inc. BLK $182.35B 26.9
Blackstone Inc. BX $162.74B 30.5
KKR & Co. Inc. KKR $99.50B 34.4

The Asset Management industry average P/E ratio is 10.3x. The Gabelli Healthcare & Wellness Trust trades at a P/E of 66.9.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Asset Management Stocks

View all Asset Management stocks →

Popular Financial Services Stocks

View all Financial Services stocks →

About The Gabelli Healthcare & Wellness Trust

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

Visit website →